ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Tempest Therpeutics Inc

Tempest Therpeutics Inc (TPST)

0.9055
0.0119
(1.33%)
Closed November 23 4:00PM
0.89
-0.0155
(-1.71%)
After Hours: 7:54PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.89
Bid
0.89
Ask
0.91
Volume
722,284
0.866001 Day's Range 0.9282
0.80 52 Week Range 6.00
Market Cap
Previous Close
0.8936
Open
0.880101
Last Trade
68
@
0.89
Last Trade Time
Financial Volume
$ 654,092
VWAP
0.905588
Average Volume (3m)
3,343,758
Shares Outstanding
43,642,072
Dividend Yield
-
PE Ratio
-1.35
Earnings Per Share (EPS)
-0.68
Revenue
-
Net Profit
-29.49M

About Tempest Therpeutics Inc

Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Tempest Therpeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TPST. The last closing price for Tempest Therpeutics was $0.89. Over the last year, Tempest Therpeutics shares have traded in a share price range of $ 0.80 to $ 6.00.

Tempest Therpeutics currently has 43,642,072 shares outstanding. The market capitalization of Tempest Therpeutics is $39 million. Tempest Therpeutics has a price to earnings ratio (PE ratio) of -1.35.

TPST Latest News

Tempest Reports Third Quarter 2024 Financial Results andΒ Provides Business Update

Building upon a successful end-of-Phase 2 meeting, received FDA β€œStudy May Proceed” letter for pivotal Phase 3 trial of amezalpat (TPST-1120) combination therapy to treat first-line HCCAnnounced...

Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma

BRISBANE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...

Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial

BRISBANE, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...

Tempest Extends Limited Duration Stockholder Rights Plan

BRISBANE, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (β€œTempest” or the β€œCompany”), a clinical-stage biotechnology company developing first-in-classi...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0364-3.929188255610.92640.93920.820436260.8732244CS
4-0.17-16.03773584911.061.210.828468841.00274856CS
12-0.47-34.55882352941.361.590.833437581.08695062CS
26-2.47-73.51190476193.363.64990.830006561.37835776CS
52-3.01-77.17948717953.960.819981352.03395552CS
156-9.68-91.579943235610.5710.570.1716122864.33980825CS
260-12.92-93.555394641613.81410.1714681884.85816231CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PDYNPalladyne AI Corporation
$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
$ 8.26
(89.02%)
2.03M
XCURExicure Inc
$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
$ 8.24
(18.05%)
107.91M

TPST Discussion

View Posts
georgie18 georgie18 2 weeks ago
TPST...$1.09...🥳...BRISBANE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that the company received a β€œStudy May Proceed” letter from the U.S. Food and Drug Administration (FDA) to evaluate amezalpat (TPST-1120) in combination with atezolizumab and bevacizumab, the current standard of care, versus the standard of care alone in a pivotal randomized Phase 3 trial for the first-line treatment of unresectable or metastatic hepatocellular carcinoma (HCC).

β€œThe clinical and regulatory team at Tempest are thrilled to receive this notice from FDA with respect to the planned pivotal Phase 3 trial to evaluate amezalpat as a potential treatment for first-line liver cancer,” said Sam Whiting M.D., Ph.D., chief medical officer and head of R&D of Tempest. β€œPreviously reported positive Phase 2 data underscore amezalpat’s potential to improve the survival of patients facing this life-threatening disease, and our team is dedicated to advancing the program and bringing amezalpat to patients.”

georgie18

Member Level
Re: None

Friday, November 08, 2024 6:22:34 PM

Post#
664322
of 664538
TPST...$1.09...Chart firming up from the .85 Range Bottom...R/S coming here...🥳
πŸ‘οΈ0
aBeezlee aBeezlee 2 weeks ago
I sold my shares, but kept the calls.
πŸ‘οΈ0
georgie18 georgie18 2 weeks ago
TPST...$1.09...Chart firming up from the .85 Range Bottom...R/S coming here...🥳
πŸ‘οΈ0
aBeezlee aBeezlee 2 weeks ago
Not a bad recovery. Will see if an ER or business report is released, then decide to sell or not.
πŸ‘οΈ0
Monksdream Monksdream 3 weeks ago
TPST , new 52 week low
πŸ‘οΈ0
stockyupydowny stockyupydowny 3 weeks ago
Agreed, we will see positive news and a boost in price prior to the split..... the higher the price the lower the split IF its even required. Should they get positive news and more support from ROCHE this can rocket and then cancel split... that's moon time!
👍️ 1
georgie18 georgie18 3 weeks ago
We shall see...🥳
πŸ‘οΈ0
aBeezlee aBeezlee 3 weeks ago
1 to 2, or 1 to 15 RS. The split doesn't make sense unless a notable event is coming. Negative sentiment will simply beat it down, and kill existing holders further.

I'm under the impression dilution is coming.
πŸ‘οΈ0
georgie18 georgie18 3 weeks ago
Yes I did...will buy back when the dust settles...🥳...made great profit with TPST and if the reverse should happen it should put this stock in the $40...imo...we shall see...
👍 1
rocketeer357 rocketeer357 3 weeks ago
Did you sell on the 14a news?
πŸ‘οΈ0
georgie18 georgie18 3 weeks ago
You saw the 14a...🥳
πŸ‘οΈ0
The GidDy uP Kid The GidDy uP Kid 4 weeks ago
aDDed after hours sub $1 range...
πŸ‘οΈ0
aBeezlee aBeezlee 4 weeks ago
RS was unexpected for something without a delisting notice. Perhaps something planned to prevent a takeover. Hmm...
πŸ‘οΈ0
georgie18 georgie18 4 weeks ago
TPST...14A Filing...Approval of a series of alternate amendments to our Restated Certificate of Incorporation to effect, at the option of our Board of Directors, a reverse stock split of our common stock at a ratio in the range of 1-for-2 to 1-for-15, inclusive, with such ratio to be determined by our Board of Directors in its sole discretion (β€œReverse Stock Split Proposal” or β€œProposal 1”).
What if another matter is properly brought before the Special Meeting?
👍 1
georgie18 georgie18 4 weeks ago
TPST....85...A/H Dip...🥳
πŸ‘οΈ0
georgie18 georgie18 4 weeks ago
Nice to have you with me on it...🥳
πŸ‘οΈ0
tw0122 tw0122 4 weeks ago
One of your GM favorites been adding myself low $1s for next blastoff to $2s ...newsand trials
πŸ‘οΈ0
georgie18 georgie18 4 weeks ago
TPST...$1.16s in the P/M...🥳

georgie18

Member Level
Re: georgie18 post# 614

Friday, October 25, 2024 12:38:28 PM

Post#
615
of 617
TPST...$1.12s clearing here...🥳Reversing...

georgie18

Member Level
Re: georgie18 post# 662364

Friday, October 25, 2024 9:43:40 AM

Post#
662715
of 662771
TPST...$1.08...Big Block Buys hitting here...🥳

georgie18

Member Level
Re: None

Wednesday, October 23, 2024 8:55:30 AM

Post#
613
of 613
TPST...Loaded $1.03 to $1.05s...🥳
πŸ‘οΈ0
aBeezlee aBeezlee 4 weeks ago
Long hold. Roche wouldn't supply them with goods if they felt phase 3 would fail. Looking for $2 on positive results.
πŸ‘οΈ0
georgie18 georgie18 4 weeks ago
Have a Great Weekend Y'all...🥳
πŸ‘οΈ0
georgie18 georgie18 4 weeks ago
TPST...$1.12s clearing here...🥳Reversing...

georgie18

Member Level
Re: georgie18 post# 662364

Friday, October 25, 2024 9:43:40 AM

Post#
662715
of 662771
TPST...$1.08...Big Block Buys hitting here...🥳

georgie18

Member Level
Re: None

Wednesday, October 23, 2024 8:55:30 AM

Post#
613
of 613
TPST...Loaded $1.03 to $1.05s...🥳
πŸ‘οΈ0
georgie18 georgie18 4 weeks ago
TPST...$1.08...Big Block Buys hitting here...🥳

georgie18

Member Level
Re: None

Wednesday, October 23, 2024 8:55:30 AM

Post#
613
of 613
TPST...Loaded $1.03 to $1.05s...🥳
πŸ‘οΈ0
georgie18 georgie18 1 month ago
TPST...Loaded $1.03 to $1.05s...🥳
πŸ‘οΈ0
Xunefox Xunefox 1 month ago
May be an AH show after all
πŸ‘οΈ0
aBeezlee aBeezlee 1 month ago
Yup TPST! I have RNAZ on list too. Buying both with next check. 🔥
πŸ‘οΈ0
georgie18 georgie18 1 month ago
TPST...$1.22...🥳...Dipping it to fill the Open Gap...another great add spot...Ran to $1.60 range in the A/H ...

georgie18

Member Level
Re: georgie18 post# 384329

Tuesday, October 15, 2024 3:37:36 PM

Post#
384411
of 384426
TPST...$1.14clearing here...🥳

georgie18

Member Level
Re: None

Friday, October 11, 2024 9:46:27 AM

Post#
603
of 603
TPST...99...great add spot....🥳
πŸ‘οΈ0
georgie18 georgie18 1 month ago
TPST …yes beauty move in the A/H…🥳
πŸ‘οΈ0
Vitamin310 Vitamin310 1 month ago
I’m in!
πŸ‘οΈ0
Money hunt Money hunt 1 month ago
TPST smell green dude!!! RNAZ Next DRUG
πŸ‘οΈ0
The GidDy uP Kid The GidDy uP Kid 1 month ago
Nice Georgie… TPST $1.61 after hours close…
πŸ‘οΈ0
aBeezlee aBeezlee 1 month ago
The next DRUG?!
πŸ‘οΈ0
georgie18 georgie18 1 month ago
TPST...$1.14clearing here...🥳

georgie18

Member Level
Re: None

Friday, October 11, 2024 9:46:27 AM

Post#
603
of 603
TPST...99...great add spot....🥳
πŸ‘οΈ0
georgie18 georgie18 1 month ago
TPST...99...great add spot....🥳
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 month ago
TPST: Nope!! Cancer is NOT trending anymore, CLOWN!!! (Nice call, IDIOT!!!)
πŸ‘οΈ0
georgie18 georgie18 1 month ago
TPST...$1.09...Great add opportunity...imo...we shall see...🥳
πŸ‘οΈ0
georgie18 georgie18 1 month ago
TPST...$1.59...from the .90 range bottom...🥳BRISBANE, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced an agreement with Roche to advance the evaluation of amezalpat (TPST-1120) in combination with atezolizumab (Tecentriq®) and bevacizumab, the current standard of care for unresectable or metastatic hepatocellular carcinoma (HCC), into a pivotal Phase 3 trial for the first-line treatment of unresectable or metastatic hepatocellular carcinoma, a form of liver cancer with high unmet need.

georgie18

Member Level
Re: None

Friday, August 09, 2024 2:43:01 PM

Post#
652989
of 660804
TPST...$1.16...Taking a hit on earnings...adding more down here...🥳
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 1 month ago
july shelf offering allows lender to sell stock at anytime
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 month ago
TPST: Hopefully!! (But is "Cancer" TRENDING anymore??)
πŸ‘οΈ0
tw0122 tw0122 1 month ago
TPST 1.82 +’35% resistance at 1.85 looks good again until 2.01- 2.23 resistance then big jump to 2.91

a pivotal Phase 3 trial for the first-line treatment of unresectable or metastatic hepatocellular carcinoma, a form of liver cancer with high unmet need.
Under the agreement, Roche will supply atezolizumab globally and Tempest will sponsor and lead the pivotal study. This agreement builds on a clinical collaboration between the companies pursuant to which amezalpat was combined with atezolizumab and bevacizumab in first-line HCC patients and compared to atezolizumab and bevacizumab alone in a randomized Phase 1b/2 study. Tempest retains all development and commercial rights to amezalpat.
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 month ago
TPST: I'm in!! Are you?? (Heck, goin' to Phase-3 with Roche?? I'll jump-on for ride!!)

πŸ‘οΈ0
Invest-in-America Invest-in-America 1 month ago
TPST: Some Roche agreement news.
πŸ‘οΈ0
georgie18 georgie18 2 months ago
TPST...$1.44s clearing on the 50MA Break...🥳
πŸ‘οΈ0
georgie18 georgie18 2 months ago
TPST...$1.50s clearing into the close...🥳
πŸ‘οΈ0
georgie18 georgie18 2 months ago
Have a Great Weekend Y'all...🥳
πŸ‘οΈ0
georgie18 georgie18 2 months ago
Nice...will be very pleased with 1/2 that target...🥳
πŸ‘οΈ0
glens0 glens0 2 months ago
Bought a starter today.
DJ Tempest Therapeutics Price Target Maintained With a $47.00/Share by HC Wainwright & Co.
12:54 PM ET 8/15/24 | Dow Jones
πŸ‘οΈ0
georgie18 georgie18 2 months ago
TPST...$1.35...🥳
πŸ‘οΈ0
georgie18 georgie18 3 months ago
TPST...$1.44...HOD...🥳
πŸ‘οΈ0
georgie18 georgie18 3 months ago
TPST...$1.50...Off the .90 range dip...🥳...was $6 recently...setting up for a Breakout...imo...we shall see...
πŸ‘οΈ0
georgie18 georgie18 3 months ago
TPST...1.4995...HOD...Beauty move off the .90 range dip...🥳Was $6 a couple of months ago...🥳
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock